A new book reveals that suspended New York Yankees slugger Alex Rodriguez was granted an exemption by Major League Baseball to use testosterone prior to his 2007 MVP season.
The book, “Blood Sport: Alex Rodriguez, Biogenesis and the Quest to End Baseball’s Steroid Era” by Tim Elfrink and Gus Garcia-Roberts, and excerpted by Sports Illustrated, outlines that Rodriguez was granted a therapeutic use exemption (TUE) in order to treat hypogonadism (a testosterone deficiency), a rarity in the sport.
“In 2007, of the 1,354 players subjected to testing, 111 were granted a TUE,” according to the book. “Only two, apparently including Rodriguez, received an exemption for ‘androgen deficiency medications,’ the category that would include testosterone.”
Rodriguez went on to win his third MVP award in 2007 after hitting 54 home runs and driving in 156 runs (both MLB highs) with a .314 average. In the offseason, Rodriguez signed a new 10-year deal with the Yankees that would pay him a guaranteed $275 million.
The book goes on to say that in 2008 Rodriguez applied for two other TUEs, one for a different treatment for testosterone deficiency (which was granted) and one for a drug thought to be helpful in weight loss (which was not granted).
“In 2008, three major leaguers were granted exemptions to take drugs to treat hypogonadism,” the book reads. “In fact, from the 2006 season through 2013, only 15 were granted for androgen deficiencies and hypogonadism, the conditions that under MLB’s drug policy could require a medical testosterone boost.”
Click here to read more.